BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 28035487)

  • 1. Application of sentinel lymph node dissection in gynecological cancers: results of a survey among German hospitals.
    Klapdor R; Hertel H; Soergel P; Jentschke M; Hillemanns P
    Arch Gynecol Obstet; 2017 Mar; 295(3):713-720. PubMed ID: 28035487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Groin Recurrences in Node Negative Vulvar Cancer Patients After Sole Sentinel Lymph Node Dissection.
    Klapdor R; Hertel H; Soergel P; Hillemanns P
    Int J Gynecol Cancer; 2017 Jan; 27(1):166-170. PubMed ID: 27870709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sentinel lymph node biopsy in vulvar cancer: status, level of knowledge, and counseling in outpatient setting.
    Röttger M; Hertel H; Kaukemüller L; Brodowski L; Flentje M; Hillemanns P; Klapdor R
    Arch Gynecol Obstet; 2020 Oct; 302(4):1001-1007. PubMed ID: 32683482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endometrial cancer-how many patients could benefit from sentinel lymph node dissection?
    Brugger S; Hamann M; Mosner M; Beer M; Braun M; Pölcher M
    World J Surg Oncol; 2018 May; 16(1):95. PubMed ID: 29773071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome After Sentinel Lymph Node Dissection in Vulvar Cancer: A Subgroup Analysis of the AGO-CaRE-1 Study.
    Klapdor R; Hillemanns P; Wölber L; Jückstock J; Hilpert F; de Gregorio N; Iborra S; Sehouli J; Habermann A; Fürst ST; Strauß HG; Baumann K; Thiel F; Mustea A; Meier W; Harter P; Wimberger P; Hanker L; Schmalfeldt B; Canzler U; Fehm T; Luyten A; Hellriegel M; Kosse J; Heiss C; Hantschmann P; Mallmann P; Tanner B; Pfisterer J; Richter B; Jäger M; Mahner S
    Ann Surg Oncol; 2017 May; 24(5):1314-1321. PubMed ID: 27896515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sentinel Lymph Node Evaluation in Early-Stage Vulvar Cancer.
    Penn CA; Schneiter MK; Watson CH
    Curr Treat Options Oncol; 2024 Jan; 25(1):20-26. PubMed ID: 38170388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current perspectives of sentinel lymph node dissection at the time of radical surgery for prostate cancer.
    Munbauhal G; Seisen T; Gomez FD; Peyronnet B; Cussenot O; Shariat SF; Rouprêt M
    Cancer Treat Rev; 2016 Nov; 50():228-239. PubMed ID: 27768918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Where Are We Going with Sentinel Lymph Node Mapping in Gynecologic Cancers?
    Reneé Franklin C; Tanner EJ
    Curr Oncol Rep; 2018 Nov; 20(12):96. PubMed ID: 30421035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indications and techniques for robotic pelvic and para-aortic lymphadenectomy with sentinel lymph node mapping in gynecologic oncology.
    Wisner KPA; Ahmad S; Holloway RW
    Best Pract Res Clin Obstet Gynaecol; 2017 Nov; 45():83-93. PubMed ID: 28533155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extended vs standard lymph node dissection in robot-assisted radical prostatectomy for intermediate- or high-risk prostate cancer: a propensity-score-matching analysis.
    Kim KH; Lim SK; Kim HY; Shin TY; Lee JY; Choi YD; Chung BH; Hong SJ; Rha KH
    BJU Int; 2013 Jul; 112(2):216-23. PubMed ID: 23356436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of sentinel node dissection on disease-free and overall tumour-specific survival in melanoma patients: a single centre group-matched analysis of 1192 patients.
    Geimer T; Sattler EC; Flaig MJ; Ruzicka T; Berking C; Schmid-Wendtner MH; Kunte C
    J Eur Acad Dermatol Venereol; 2017 Apr; 31(4):629-635. PubMed ID: 27556957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accuracy of sentinel lymph node dissection for melanoma staging in the presence of a collision tumour with a lymphoproliferative disease.
    Gero D; Queiros da Mota V; Boubaker A; Berthod G; de Leval L; Demartines N; Matter M
    Melanoma Res; 2014 Aug; 24(4):371-6. PubMed ID: 24922190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic Accuracy of Magnetometer-Guided Sentinel Lymphadenectomy After Intraprostatic Injection of Superparamagnetic Iron Oxide Nanoparticles in Intermediate- and High-Risk Prostate Cancer Using the Magnetic Activity of Sentinel Nodes.
    Geißen W; Engels S; Aust P; Schiffmann J; Gerullis H; Wawroschek F; Winter A
    Front Pharmacol; 2019; 10():1123. PubMed ID: 31680943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sentinel lymph node dissection provides axillary control equal to complete axillary node dissection in breast cancer patients with lobular histology and a negative sentinel node.
    Khakpour N; Hunt KK; Kuerer HM; Yi M; Meric-Bernstam F; Ross MI; Lucci A
    Am J Surg; 2005 Oct; 190(4):598-601. PubMed ID: 16164930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paucity of data evaluating patient centred outcomes following sentinel lymph node dissection in endometrial cancer: A systematic review.
    Obermair HM; O'Hara M; Obermair A; Janda M
    Gynecol Oncol Rep; 2021 May; 36():100763. PubMed ID: 33869716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is Sentinel Lymph Node Dissection Necessary in All Patients with Ductal Carcinoma In Situ Undergoing Total Mastectomy?
    Bonev V; De Paz Villanueva CC; Solomon N; Senthil M; Reeves ME; Garberoglio C; Lum SS
    Am Surg; 2016 Oct; 82(10):982-984. PubMed ID: 27779988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymph node evaluation in high-risk early stage endometrial cancer: A multi-institutional retrospective analysis comparing the sentinel lymph node (SLN) algorithm and SLN with selective lymphadenectomy.
    Buda A; Gasparri ML; Puppo A; Mereu L; De Ponti E; Di Martino G; Novelli A; Tateo S; Muller M; Landoni F; Papadia A
    Gynecol Oncol; 2018 Aug; 150(2):261-266. PubMed ID: 29887483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [SENTINEL LYMPH NODES DISSECTION IN GYNECOLOGICAL MALIGNANCIES].
    Naaman Y; Goldenhersh L; Ben-Arie A
    Harefuah; 2017 Feb; 156(2):96-99. PubMed ID: 28551895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. F-18 fluoro-D-glucose (FDG)-positron emission tomography (PET)/computed tomography (CT) in planning of surgery and sentinel lymph node screening in vulvar cancers.
    Dolanbay M; Ozcelik B; Abdulrezzak U; Serin IS; Kutuk MS; Uludag S
    Arch Gynecol Obstet; 2016 Jun; 293(6):1319-24. PubMed ID: 26498604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sentinel lymph node biopsy in the management of gynecologic cancer.
    Cibula D; Oonk MH; Abu-Rustum NR
    Curr Opin Obstet Gynecol; 2015 Feb; 27(1):66-72. PubMed ID: 25502426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.